Saccharomyces boulardii CNCM I-745 modulates the fecal bile acids metabolism during antimicrobial therapy in healthy volunteers

19Citations
Citations of this article
50Readers
Mendeley users who have this article in their library.

Abstract

Saccharomyces boulardii CNCM I-745 (SB) is a probiotic yeast used to lower the incidence of antibiotic-associated Clostridium difficile (C. difficile) infection, though its mechanism of action remains unclear. Cholic acid is a primary bile acid, which triggers the germination and promotes the growth of C. difficile. The intestinal microbiota transforms primary into secondary bile acids. This study examined (1) the antimicrobial-induced alteration of fecal bile acid content, and (2) whether the concomitant administration of SB influences this transformation. This is an ancillary work from a randomized study, which revealed that SB modulates fecal microbiota dysbiosis during antibiotic treatment. Healthy subjects were randomly assigned to (1) SB only, (2) amoxicillin-clavulanate (AC), (3) SB plus AC, or (4) no treatment. We analyzed fecal concentrations of BA by high performance liquid chromatography/tandem mass spectrometry. Compared to the untreated or the SB-treated groups, AC decreased the percentage of fecal secondary BA significantly (days 3 and 7). When SB and AC were administered concomitantly, this decrease in secondary BA was no longer significant. Following treatment with AC, a significant peak of fecal CA was measured on days 3 and 7, which was prevented by the concomitant administration of SB. AC administered to healthy volunteers altered the microbial transformation of primary BA, decreased secondary BA, and increased CA. The latter was prevented by the concomitant administration of SB and AC, suggesting a potent mechanism protection conferred by SB against post-antimicrobial C. difficile infection.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Kelly, C. P., Nguyen, C. C., Palmieri, L. J., Pallav, K., Dowd, S. E., Humbert, L., … Duboc, H. (2019). Saccharomyces boulardii CNCM I-745 modulates the fecal bile acids metabolism during antimicrobial therapy in healthy volunteers. Frontiers in Microbiology, 10(MAR). https://doi.org/10.3389/fmicb.2019.00336

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 18

72%

Researcher 4

16%

Professor / Associate Prof. 2

8%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 9

35%

Biochemistry, Genetics and Molecular Bi... 7

27%

Agricultural and Biological Sciences 6

23%

Nursing and Health Professions 4

15%

Save time finding and organizing research with Mendeley

Sign up for free